A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria

PHASE4CompletedINTERVENTIONAL
Enrollment

505

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Pneumococcal Infections
Interventions
BIOLOGICAL

Prevenar

"Dosage form: intramuscular injection Dosage: 0.5 ml~Frequency:~4 doses starting from 121 to \< 212 days of age"

BIOLOGICAL

Prevenar

"Dosage form: intramuscular injection Dosage: 0.5 ml~Frequency:~3 doses starting from 212 days to \< 12 months of age"

BIOLOGICAL

Prevenar

"Dosage form: intramuscular injection Dosage: 0.5 ml~Frequency:~2 doses starting from 12 months to \< 24 months of age"

BIOLOGICAL

Prevenar

"Dosage form: intramuscular injection Dosage: 0.5 ml~Frequency:~1 dose starting from 24 months to \< 72 months of age"

Trial Locations (5)

541800

Yongfu County CDC, Yongfu County

Yongfu County Clinic, Yongfu County

541801

Luojin Clinic, Luojin Town, Yongfu County

541803

Guangfuxiang Clinic, Guangfu Town, Yongfu County

541902

Baolixiang Clinic, Baoli Town,Yongfu County

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY